Regular walnut consumption linked to health and longevity in women

According to a new epidemiological study, women in their late 50s and early 60s who consumed at least two servings of walnuts per week had a greater likelihood of healthy aging compared to those who did not eat walnuts. After accounting for various factors that could impact health in older adults, such as education and physical activity, walnuts were the only nut associated with significantly better odds of healthy aging.

In this study, which was supported by the California Walnut Commission, "healthy aging" was defined as longevity with sound mental health and no major chronic diseases, cognitive issues or physical impairments following the age of 65.

By 2034, for the first time ever, older adults will outnumber children. Baby boomers (those 65 and older) are expected to make up 21% of the population, with more than half being women. The significance of this demographic turning point in our country's history is clear - research that examines the aging process, including simple, low-cost interventions like healthy food choices, will be especially crucial to healthier lifespans.

Previous research from primary investigator Dr. Francine Grodstein, formerly of Brigham and Women's Hospital, has found that eating walnuts may have a positive impact on reducing the risk for physical impairments in older adults as well as cognitive decline. Additionally, others in the same research group have found decreases in cardiovascular disease and type 2 diabetes - all conditions that become more common as we age. There is no one solution to slowing down the effects of aging, but adopting the right habits, like snacking on a handful of walnuts, can help.

In this study, Grodstein looked at data from 33,931 women in the Nurses' Health Study (NHS) to evaluate the association between nut consumption and overall health and well-being in aging. Between 1998-2002, female nurses in the NHS were asked about their diet (including total nut consumption); evaluated for chronic diseases (such as cancer, heart attack, heart failure, stroke, type 2 diabetes and Parkinson's disease); and assessed for memory concerns, mental health and physical limitations (including daily activities like walking one block, climbing a flight of stairs, bathing, dressing oneself and pushing a vacuum cleaner). Of the study participants, 16% were found to be "healthy agers," defined as having no major chronic diseases, reported memory impairment or physical disabilities as well as having intact mental health.

Although previous research has connected a healthy diet, including walnuts, to better physical function among older men and women, this study only included women. More research is needed to understand if these results hold true among men. Additionally, participants were not assigned to eat walnuts or other foods; they were simply asked about their dietary choices. It is possible that subjects misreported their dietary intake since this information was collected by questionnaires. As an observational study, this does not prove cause and effect. However, this research sheds light on simple habits that can influence health during later years in life - such as eating walnuts.

Tania-Marisa Freitas-Simoes, Maude Wagner, Cecilia Samieri, Aleix Sala-Vila, Francine Grodstein.
Consumption of Nuts at Midlife and Healthy Aging in Women.
Journal of Aging Research, 2020, Article ID 5651737. doi: 10.1155/2020/5651737.

Most Popular Now

Lilly will supply an additional 150,000 doses of b…

Eli Lilly and Company (NYSE: LLY) announced a modified purchase agreement with the U.S. government to supply an additional 150,000 doses of bebtelovimab for approximately...

Bayer to sell men's health product Nebido™ to Grün…

Bayer and Grünenthal have entered into a definitive agreement regarding the sale of Bayer's men's health product Nebido™ (testosterone undecanoate), for a purchase price ...

Pfizer and BioNTech complete submission to Europea…

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they have completed a submission to the European Medicines Agency (EMA) for an Omicron-adapted biva...

The fourth COVID-19 vaccine reduces the risk of de…

A new study by Tel Aviv University and Ben Gurion University of the Negev, in collaboration with the Israeli Ministry of Health, has found that the fourth COVID-19 vaccin...

Vaccine protection against COVID-19 short-lived, b…

Since COVID-19 vaccines first became available to protect against infection and severe illness, there has been much uncertainty about how long the protection lasts, and w...

AstraZeneca to acquire TeneoTwo and its clinical-s…

AstraZeneca announced an agreement to acquire TeneoTwo, Inc. (TeneoTwo)i, including its Phase I clinical-stage CD19/CD3 T-cell engager, TNB-486, currently under evaluatio...

Demonstration of a potent, universal coronavirus m…

The SARS-CoV-2 that causes COVID-19 has killed 6.3 million people worldwide since 2019, painfully highlighting the vulnerability of humanity to novel coronaviruses. Re...

Research shows investigational drug fosters nerve …

Scientists from the University of Birmingham have shown that a brain-penetrating candidate drug currently in development as a cancer therapy can foster regeneration of da...

NIH launches clinical trial of mRNA Nipah virus va…

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched an early-stage clinical trial evaluating an inv...

Anti-inflammatory compound shows potential in trea…

An anti-inflammatory compound may have the potential to treat systemic inflammation and brain injury in patients with severe COVID-19 and significantly reduce their chanc...

Vaccine-induced immune response to omicron wanes s…

Although COVID-19 booster vaccinations in adults elicit high levels of neutralizing antibodies against the Omicron variant of SARS-CoV-2, antibody levels decrease substan...

SARS-CoV-2 hijacks nanotubes between neurons to in…

COVID-19 often leads to neurological symptoms, such as a loss of taste or smell, or cognitive impairments (including memory loss and concentration difficulties), both dur...